⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 27, 2023Nephrology Dialysis TransplantationOpen Access

Vaccinated kidney transplant recipients are yet not sufficiently protected against COVID-19

A. Lianne Messchendorp Ron T. Gansevoort

View Full Paper

Ask AI

Bookmark

Share

Abstract

A Lianne Messchendorp, Ron T Gansevoort; Vaccinated kidney transplant recipients are yet not sufficiently protected against COVID-19, Nephrology Dialysis Transp

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Messchendorp et al. (2023) studied this question.

synapsesocial.com/papers/6aa4379e5b75cc9dd9c97c18 https://doi.org/10.1093/ndt/gfad127

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaborationPrognostic Study · 2020 · 393 citations
2Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine2020 · 14,588 citations
3Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineClinical Trial · 2020 · 10,107 citations
4Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKDReview · 2021 · 113 citations
5The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantOriginal Research · 2021 · 188 citations

Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy2022
Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses2021
Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients2022
Autosomal dominant polycystic kidney disease in ItalyNephrology Dialysis Transplantation · 2026
Efficacy and safety of eculizumab in patients with anti-glomerular basement membrane disease: an investigator-initiated, open-label, phase II clinical trialNephrology Dialysis Transplantation · 2026

More from Nephrology Dialysis Transplantation

More from University of Groningen

More from University Medical Center Groningen